Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
XENE
XENE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
XENE News
Xenon Pharmaceuticals Reports Significant Efficacy of Azetukalner in Epilepsy Studies
19h ago
Yahoo Finance
AAN Meeting: Azetukalner Significantly Reduces Seizure Frequency in Epilepsy
19h ago
Newsfilter
Xenon Pharmaceuticals to Present at Four Investor Conferences
5d ago
Newsfilter
Xenon Pharmaceuticals Presents New Drug Study Results at AAN Meeting
Apr 07 2026
Newsfilter
Xenon Pharmaceuticals CMO Sells Shares Amid RSU Vesting
Mar 27 2026
Fool
Driehaus Capital Increases Stake in Xenon Pharmaceuticals
Mar 13 2026
Fool
Xenon Pharmaceuticals Prices $650 Million Upsized Public Offering
Mar 11 2026
NASDAQ.COM
Xenon Pharmaceuticals Upsizes Public Offering to $650 Million
Mar 11 2026
seekingalpha
Wall Street Analysts Adjust Ratings
Mar 10 2026
Benzinga
Xenon Pharmaceuticals Stock Surpasses Analyst Target Price
Mar 10 2026
NASDAQ.COM
Xenon Plans New Drug Application Submission
Mar 10 2026
stocktwits
Xenon and Relmada Surge on Positive Drug Data
Mar 09 2026
Yahoo Finance
Xenon Pharmaceuticals Launches $500 Million Public Offering
Mar 09 2026
seekingalpha
Xenon Pharmaceuticals Reports Positive Phase 3 X-TOLE2 Study Results
Mar 09 2026
seekingalpha
U.S. Stocks Close Sharply Lower Amid Mixed Trading
Mar 09 2026
Benzinga
Oil Price Surge Drives Significant Stock Movements
Mar 09 2026
CNBC
Show More News
